Camber Capital Management’s CONMED CNMD Stock Holding History

Camber Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-325,000	Closed	-$33.8M	–	40
2023 Q1	$33.8M	Buy	+325,000	New	+$31.4M	1.04%	20
2017 Q1	–	Sell	-750,000	Closed	-$33.1M	–	36
2016 Q4	$33.1M	Hold	750,000	–	–	1.73%	23
2016 Q3	$30M	Buy	+750,000	New	+$31.8M	1.32%	22
2015 Q2	–	Sell	-670,943	Closed	-$33.9M	–	46
2015 Q1	$33.9M	Sell	670,943 -714,057	-52%	-$35M	2.42%	19
2014 Q4	$62.3M	Hold	1,385,000	–	–	4.14%	6
2014 Q3	$51M	Hold	1,385,000	–	–	4.79%	7
2014 Q2	$61.1M	Hold	1,385,000	–	–	4.01%	6
2014 Q1	$60.2M	Hold	1,385,000	–	–	4.72%	6
2013 Q4	$58.9M	Buy	1,385,000 +385,000	+39%	+$14.6M	5.19%	6
2013 Q3	$34M	Hold	1,000,000	–	–	3.56%	12
2013 Q2	$31.2M	Buy	+1,000,000	New	+$32.4M	3.21%	12

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Camber Capital Management's CNMD Position: Q2 2023 in Review

Camber Capital Management sold out of CONMED (CNMD) in Q2 2023, closing a stake of 325,000 shares — an estimated $33.8M sold.

Camber Capital Management first reported a position in CNMD in Q2 2013 and held it in 11 quarters. The position peaked at $62.3M in Q4 2014. 263 funds tracked by Wall St. Rank hold CNMD as of Q2 2023.

Camber Capital Management reported no remaining CONMED position as of Q2 2023 after selling out during the quarter.
Camber Capital Management sold 325,000 CONMED shares in Q2 2023, an estimated $33.8M.
Camber Capital Management first reported a position in CONMED in Q2 2013 and held it in 11 quarters.
Camber Capital Management's CONMED position peaked at $62.3M in Q4 2014.
263 funds tracked by Wall St. Rank held CONMED as of Q2 2023.

Based on Camber Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.